LEP and endothelial dysfunction: Emerging biomarkers of endothelial dysfunction, including neopterin, osteoprotegerin, fetuin-A, homocysteine, leptin, adiponectin, PAI-1, CRP, IL-6, and CECs, provide additional understanding of the pathophysiology of endothelial damage.